Director Patrick G. Enright buys $18.3 million of Veradermics, Inc (MANE)

Patrick G. Enright, director of Veradermics, Inc, bought 1,075,000 shares on the open market on February 5, 2026 at an average of $17.00 a share, for a total of $18.3 million. The purchase was reported to the SEC on Form 4 on February 5, 2026.

It raised their holding by 110%, to 2,053,474 shares.

4 other insiders also bought at least $10,000 of MANE within 30 days, which makes this a cluster buy.

In the 12 months up to this filing, Veradermics, Inc insiders reported 4 open-market purchases and 0 sales.

WallStPal Score: 62 out of 100, because of raised their holding by 110%; a large purchase; 4 other insiders also bought.

What happened next: after 1 month the stock was up 178.5% (179.4 points better than the S&P 500); after 3 months the stock was up 488.8% (485.6 points better than the S&P 500); after 6 months the stock was up 499.4% (491.4 points better than the S&P 500). Based on weekly prices from the week of the purchase.

Our read

It is one of 4 insider purchases at MANE in the past year, the first open-market purchase by Patrick G. Enright in our records. Insiders buy for many reasons and can be wrong; one purchase is a reason to look closer, not a reason to buy.

Source: SEC Form 4 filing ↗. This story was written automatically from the filing and weekly price data. Information, not investment advice.

Examples

Big insider purchases have made news before. In January 2016, with bank stocks falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares, about $26 million of his own money, and the purchase was widely reported as a sign of confidence.

Explain it like I'm 13

Patrick G. Enright helps run Veradermics, Inc. Spending $18.3 million of their own money on the company's stock is like a coach buying a big stack of tickets to their own team's games: it suggests they think the team will do well. It is not a promise, and insiders can be wrong.

More: all MANE insider trades · Patrick G. Enright's track record